Hours

Minutes

Seconds

-40%

on all subscriptions*

Last hours

Enjoy this offer

* See conditions under "Our services"

Ortivus AB is a Sweden-based provider of mobile solutions for modern emergency medical services. The Company is engaged in the development of mobile surveillance and communication solutions, forming a decision support system. Its offering comprises: MobiMed Smart, a decision support system, which allows ambulance personnel to handle documentation, monitoring and introduce a structured approach in prehospital care; CoroNet, a mobile surveillance solution which allows patients to move freely under supervision of medical staff and provides healthcare professionals with monitoring information. In addition, the Company provides a wide range of services, such as support, implementation, training and consulting, among others. The Companyâ€™s customer base includes mainly ambulance services and emergency departments.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

25/08 - Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
18/26/18	1.835 kr	+0.55%	25
17/26/17	1.825 kr	-3.18%	13,116
16/26/16	1.885 kr	+4.72%	15,098
15/26/15	1.800 kr	0.00%	260
12/26/12	1.800 kr	0.00%	225

Delayed Quote Nasdaq Stockholm

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Nasdaq Stockholm Other stock markets 09:30:00 18/06/2026 pm IST			5-day change	1st Jan Change
1.835 ^SEK	+0.55%		+1.94%	+51.03%

07/05	Ortivus AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04/05	Ortivus Exits H&E Solutions Shareholding	MT

Market Cap	16Cr 1.7Cr 1.48Cr 1.37Cr 1.29Cr 2.41Cr 160.63Cr 2.43Cr 6.32Cr 79Cr 6.39Cr 6.25Cr 274.53Cr	P/E 2024	-2.47x	P/E 2025	-2.86x
Enterprise Value	17Cr 1.81Cr 1.58Cr 1.46Cr 1.37Cr 2.57Cr 171.11Cr 2.59Cr 6.73Cr 84Cr 6.81Cr 6.66Cr 292.44Cr	EV / Sales 2024	1.19x	EV / Sales 2025	1.61x
Free-Float	83.17%	Yield 2024 *	-	Yield 2025	-

07/05	Ortivus AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04/05	Ortivus Exits H&E Solutions Shareholding	MT
04/05	Ortivus completes sale of its holding in H&E Solutions	RE
21/04	Ortivus AB Appoints Matti Zemack as New Chief Product Officer	CI
19/02	Ortivus AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
04/02	19 Stocks Reach New 52-Week Highs on the Stockholm Stock Exchange So Far Today	FW
13/01	Ponderus Invest has announced final outcome of cash offer to shareholders of Ortivus	RE
12/01	Ponderus Invest AB completed the acquisition of remaining 39.42% stake in Ortivus AB (OM:ORTI B).	CI
22/12	Ponderus announces approval regarding cash offer to shareholders of Ortivus	RE
18/12	Ortivus: Independent bid committee unanimously recommends to not accept mandatory cash offer	RE
17/12	Ortivus: Appointment of Minni Raij as CFO	RE
17/12	Ortivus AB Appoints Minni Raij As Chief Financial Officer, Effective February 16, 2026	CI
02/12	Ponderus Invest AB proposed to acquire remaining 39.42% stake in Ortivus AB (OM:ORTI B) for approximately SEK 42.6 million.	CI

27/05	PRESS RELEASE	AQ
07/05	Interim Report for Ortivus AB (publ) for the period January-March 2026	AQ
04/05	Ortivus AB completes sale of its holding in H&E Solutions AB and realises a profit	AQ
21/04	Ortivus AB welcomes Matti Zemack as new Chief Product Officer	AQ
31/03	Ortivus AB publishes the Annual Report of 2025	AQ

Ortivus AB Share Price

Stocks

ORTI B

SE0000123085

Advanced Medical Equipment & Technology

Valuation: Ortivus AB

Chart: Ortivus AB

Latest news : Ortivus AB

Press Releases: Ortivus AB

Quotes and Performance

Course Extremes

Managers and Directors: Ortivus AB

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

1 day	+0.55%
1 week	+1.94%
Current month	+1.94%
1 month	-0.27%
3 months	+31.54%
6 months	+51.65%
Current year	+51.03%

1 week	1.65	1.99
1 month	1.55	2
Current year	1.14	2.14
1 year	0.8	2.14
3 years	0.8	4.99
5 years	0.8	7.74
10 years	0.8	8.9

Manager	Title	Age	Since
Gustaf Nordenhök CEO	Chief Executive Officer	-	01/01/2024
Minni Raij DFI	Director of Finance/CFO	-	16/02/2026
Gabriel Åhbeck CTO	Chief Tech/Sci/R&D Officer	55	01/01/2013

Director	Title	Age	Since
Peter Edwall BRD	Director/Board Member	71	01/01/2008
Anna Klevby Dalgaard BRD	Director/Board Member	47	01/01/2017
Jarnberg Ulf BRD	Director/Board Member	62	01/01/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ORTIVUS AB	+0.55%	+1.94%	+39.54%	-57.23%	1.7Cr
THERMO FISHER SCIENTIFIC, INC.	+0.63%	-1.01%	+18.35%	-13.53%	17TCr
INTUITIVE SURGICAL, INC.	+1.14%	-1.04%	-20.16%	+23.51%	14TCr
DANAHER CORPORATION	-0.33%	-1.63%	-8.88%	-26.73%	13TCr
BOSTON SCIENTIFIC CORPORATION	+0.76%	-3.45%	-55.32%	-16.62%	6.73TCr
EDWARDS LIFESCIENCES CORPORATION	+0.78%	+2.64%	+18.09%	-4.98%	5.03TCr
SIEMENS HEALTHINEERS AG	-0.58%	-1.16%	-25.42%	-34.65%	4.38TCr
AGILENT TECHNOLOGIES, INC.	+2.20%	-2.14%	+9.99%	+4.90%	3.59TCr
WATERS CORPORATION	-0.44%	-0.03%	+4.74%	+32.04%	3.49TCr
GE HEALTHCARE TECHNOLOGIES INC.	+0.72%	-5.51%	-14.33%	-21.69%	2.8TCr
Average	+0.54%	-1.48%	-3.34%	-11.50%	7.02TCr
Weighted average by Cap.	+0.54%	-1.89%	-6.63%	-6.41%

	2024	2025
Net sales	8.04Cr 83.94L 73.19L 67.78L 63.45L 1.19Cr 79Cr 1.2Cr 3.12Cr 39Cr 3.15Cr 3.08Cr 135.37Cr	7.34Cr 76.62L 66.81L 61.87L 57.92L 1.09Cr 72Cr 1.09Cr 2.84Cr 36Cr 2.88Cr 2.81Cr 123.56Cr
Net income	-2.49Cr -26L -22.67L -20.99L -19.65L -36.85L -25Cr -37.08L -96.51L -12Cr -97.58L -95.49L -42Cr	-2.19Cr -22.84L -19.91L -18.44L -17.26L -32.37L -22Cr -32.57L -84.78L -11Cr -85.72L -83.88L -37Cr
Net Debt	3.07Cr 32.1L 27.99L 25.92L 24.26L 45.51L 30Cr 45.78L 1.19Cr 15Cr 1.2Cr 1.18Cr 52Cr	1.06Cr 11.11L 10L 9L 8L 15.74L 10Cr 15.84L 41.23L 5.16Cr 41.69L 40.79L 18Cr